Monday, May 20, 2019, Health and Human Services Secretary Alex Azar is participating in the 72nd World Health Assembly (WHA) as head of the U.S. delegation. Since arriving in Geneva, Switzerland, Secretary Azar has delivered the U.S. plenary statement and participated in multiple bilateral meetings with his counterparts. In his plenary address, Secretary Azar emphasized ...
Today, May 18, 2019, Health and Human Services Secretary Alex Azar participated in a meeting with the Pasteur Institute. He and other U.S. health officials met with Stewart Cole, President of the Pasteur Institute, and other members of the Institute’s senior leadership team. They discussed the history of the Pasteur Institute and the continued collaboration ...
Today, May 17, 2019, Health and Human Services Secretary Alex Azar participated in bilateral meetings with health ministers, attended the final day of the G7 Health Ministerial Meeting in Paris, France, as the head of the U.S. delegation, and attended a Global Health Security Initiative (GHSI) Special Ministerial Meeting on Ebola. In the morning, Secretary ...
Today, May 16, 2019, Health and Human Services Secretary Alex Azar participated in bilateral meetings with health ministers and attended the first day of the G7 Health Ministerial Meeting in Paris, France, as the head of the U.S. delegation. First, Secretary Azar participated in a bilateral meeting with Agnès Buzyn, France’s Minister of Solidarity and ...
Adm. Brett P. Giroir, M.D., Health and Human Services Assistant Secretary for Health and Senior Advisor to the Secretary for Opioid Policy, announced today the creation of a new committee to identify areas for improved coordination related to substance use disorder (SUD) research, services, supports and prevention activities across all relevant federal agencies. HHS, in ...
Health and Human Services Secretary Alex M. Azar II announced today that, as a result of discussions between the Trump Administration and Gilead Sciences, Inc., the pharmaceutical company has agreed to donate pre-exposure prophylaxis (PrEP) medication for up to 200,000 individuals each year for up to 11 years. PrEP is used to reduce the risk ...
The Pain Management Best Practices Inter-Agency Task Force, a federal advisory committee, will be voting on final recommendations for pain management best practices at its May 9-10 meeting to be held at the Hubert H. Humphrey Building, 200 Independence Avenue, SW, Washington, D.C. The Task Force, which was established by the Comprehensive Addiction and Recovery ...
Health and Human Services Secretary Alex Azar released the following statement regarding President Trump’s announcement of principles for legislation addressing surprise medical billing: “Laying out principles for Congress to address surprise billing is another major step in President Trump’s efforts to deliver on this commitment: You, as the American patient, have the right to know ...
“If we want to have a real market for drugs, why not have [companies] disclose their prices in the ads, too? Consumers would have much more balanced information, and companies would have a very different set of incentives for setting their prices.” – HHS Secretary Alex Azar – In May 2018, President Trump and Secretary ...
Less than a year after the release of President Trump’s American Patients First blueprint, HHS finalizes first rule implementing the blueprint, aimed at increasing transparency for patients and bringing down overall drug costs both for patients and for the Medicare and Medicaid programs. On Wednesday, Health and Human Services Secretary Alex Azar announced a final ...
